¼¼°èÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¿¹Ãø(-2032³â)
Global IPS Cell Derived Organoids Market Research Report Information by Type, by Application, by End User, and by Region Forecast till 2032
»óǰÄÚµå : 1607749
¸®¼­Ä¡»ç : Market Research Future
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 101 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù.
US $ 5,950 £Ü 8,609,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù.
US $ 7,250 £Ü 10,490,000
PDF & Excel (Enterprise License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÌ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇϸç, Àμ⠰¡´ÉÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 4,000¸¸ ´Þ·¯, 2024³â 5¾ï 1,000¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 17.8%ÀÇ CAGRÀ» ±â·ÏÇϸç 2032³â¿¡´Â 18¾ï 9,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀåÀº »ý¹° ÀÇÇÐ ¿¬±¸ ¹× ÀǾàǰ °³¹ßÀÇ È¹±âÀûÀÎ ¹ßÀüÀ» »ó¡ÇÕ´Ï´Ù. ÀΰøÁٱ⼼Æ÷(iPS ¼¼Æ÷)·Î ¸¸µç ÀÌ ¼ÒÇü 3Â÷¿ø Á¶Á÷ ¸ðµ¨Àº Àΰ£ »ý¸®ÇÐ, Áúº´ ¸ÞÄ¿´ÏÁò, ¾àÈ¿¸¦ ¿¬±¸ÇÒ ¼ö ÀÖ´Â Àü·Ê ¾ø´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. iPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀ̵å´Â Áúº´ ¸ðµ¨, ½Å¾à °³¹ß, ¸ÂÃã ÀÇ·á, Àç»ý Ä¡·á µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, iPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀåÀº ±â¼ú ¹ßÀü, ¸ÂÃã ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½Å¾à °³¹ß ¹× Àç»ýÀÇ·á ºÐ¾ß¿¡¼­ÀÇ Àû¿ë È®´ë¿¡ ÈûÀÔ¾î Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÇÑÆí, ÀÌ Çõ½ÅÀûÀÎ ±â¼úÀÇ ÀáÀç·ÂÀ» ÃÖ´ëÇÑ ¹ßÈÖÇϱâ À§Çؼ­´Â ±â¼úÀû, ±ÔÁ¦Àû, À±¸®Àû ¹®Á¦¸¦ ±Øº¹ÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

ºÏ¹Ì IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀåÀº źźÇÑ ¿¬±¸ ÀÎÇÁ¶ó, »ý¸í°úÇп¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ, Ȱ¹ßÇÑ »ý¸í°øÇÐ »ê¾÷À» º¸À¯Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡´Â Áٱ⼼Æ÷ ¿¬±¸ÀÇ ÃÖÀü¼±¿¡ ÀÖ´Â ¿©·¯ ÀÏ·ù ´ëÇаú ¿¬±¸¼¾ÅͰ¡ ÀÖÀ¸¸ç, iPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀ̵åÀÇ °³¹ß ¹× ÀÀ¿ëÀ» ÃËÁøÇϱâ À§ÇØ ¹Î°ü ¾çÃøÀ¸·ÎºÎÅÍ ¸¹Àº ÅõÀÚ¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ÀÇ·áÁ¦µµ°¡ Àß È®¸³µÇ¾î ÀÖ¾î ¼±Áø ÀÇ·á±â¼ú µµÀÔÀÌ ¿ëÀÌÇÕ´Ï´Ù. Á¤±³ÇÑ ¿¬±¸ ½Ã¼³°ú ¼÷·ÃµÈ Àü¹®°¡µéÀÇ Á¸Àç´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ±â¼ú µµÀÔ¿¡ ´ëÇÑ ³ë·ÂÀº À¯±âü ±â¹Ý Ç÷§ÆûÀÇ °³¹ß ¹× Àû¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯±âü ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©µµ À¯±âü ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

À¯·´Àº ÇコÄɾ ´ëÇÑ °ü½É°ú °­·ÂÇÑ °úÇÐ Ä¿¹Â´ÏƼ°¡ ½ÃÀåÀ» ÁÖµµÇϰí Àֱ⠶§¹®¿¡ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå¿¡¼­ µÎ ¹øÂ°·Î Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. µ¶ÀÏÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå °ø±Þ¾÷ü°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÇÁ¶û½ºÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå °ø±Þ¾÷ü´Â ÀÌ Áö¿ª¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀåÀº 2023³âºÎÅÍ 2032³â±îÁö »ýÀÇÇÐ ¿¬±¸ ÅõÀÚ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡·Î ÀÎÇÑ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ¿¬±¸ ¹× °³¹ß ÃËÁøÀ¸·Î ÀÎÇØ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¢Á¾ ¿µÇâ¿äÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° ºÐ¼®, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½ÃÀå ¿äÀÎ ºÐ¼®

Á¦6Àå ¼¼°èÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå : À¯Çüº°

Á¦7Àå ¼¼°èÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå : ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°èÀÇ IPS ¼¼Æ÷ À¯·¡ ¿À°¡³ëÀÌµå ½ÃÀå : Áö¿ªº°

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Forecast till 2032

An Overview of the Market

IPS Cell Derived Organoids Market size was valued at USD 0.44 billion in 2023. The IPS Cell Derived Organoids Market industry is projected to grow from USD 0.51 billion in 2024 to USD 1.89 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period (2024 - 2032).

IPS cell-derived organoids market represent a revolutionary advancement in biomedical research and drug development. These miniature, three-dimensional tissue models, generated from induced pluripotent stem cells (iPSCs), offer unprecedented opportunities for studying human physiology, disease mechanisms, and drug efficacy. Organoids are used in various applications, including disease modelling, drug discovery, personalized medicine, and regenerative therapies. The iPS cell-derived organoids market is poised for substantial growth, driven by technological advancements, increasing demand for personalized medicine, and expanding applications in drug discovery and regenerative medicine. However, overcoming technical, regulatory, and ethical challenges will be crucial for realizing the full potential of this transformative technology.

Market segmentation insights

The IPS Cell Derived Organoids Market segmentation, based on type, includes Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others.

The IPS Cell Derived Organoids Market segmentation, based on application, includes drug discovery and development, disease modelling, and regenerative medicine.

Regional Insights

The IPS Cell Derived Organoids market in America boasts a robust research infrastructure, substantial investments in life sciences, and a thriving biotechnology industry. North America is home to several top-tier universities and research centers that are at the forefront of stem cell research. This region has seen substantial investments from both public and private sectors aimed at advancing the development and application of iPS cell-derived organoids. The well-established healthcare systems in North America facilitate the adoption of advanced medical technologies. The presence of sophisticated laboratory facilities and skilled professionals further supports market growth. The region's inclination towards technological adoption has fostered the development and application of organoid-based platforms. Supportive regulatory frameworks encourage investments in organoid research and development.

Europe IPS Cell Derived Organoids market accounted for the second-largest market share due to region's emphasis on healthcare, coupled with a strong scientific community, drives the market. Furthermore, the Germany IPS Cell Derived Organoids provider attributed to hold the largest market share, and the France IPS Cell Derived Organoids providers is projected be the fastest growing market in the Europe region.

The Asia-Pacific IPS Cell Derived Organoids market is expected to be the fastest growing from 2023 to 2032 due to increasing investments in biomedical research, growing healthcare expenditure, and a rising prevalence of chronic diseases can support IPS Cell Derived Organoids development.

Prominent Participants

Key Companies in the IPS Cell Derived Organoids market includes ACROBiosystems (US), Miltenyi Biotec (Germany), ThermoFisher Scientific (US), STEMCELL Technologies (Canada), Bio-Techne (US), Merck KGaA (Germany), Molecular Devices, LLC (US), Corning Incorporated (US), Promega Corporation (US), and Creative Bioarray (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE

7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION

8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER

9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â